CVRX vs LFST vs LIVN vs ACHC vs UHS

For growth investors, LifeStance Health Group, Inc.

(LFST) is the stronger pick with 13. 9% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). Universal Health Services, Inc. (UHS) offers the better valuation at 7. 4x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate CVRx, Inc. (CVRX) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Universal Health Services, Inc.

(UHS) is the cheapest at 7. 4x versus LifeStance Health Group, Inc. at 442. 5x. On forward P/E, Universal Health Services, Inc. is actually cheaper at 7. 3x.

Over the past 5 years, Universal Health Services, Inc.

(UHS) delivered a total return of +12. 5%, compared to -73. 9% for CVRx, Inc. (CVRX). Over 10 years, the gap is even starker: LIVN returned +48. 1% versus CVRX's -75. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Universal Health Services, Inc.

(UHS) is the lower-risk stock at 0. 62β versus CVRx, Inc. 's 1. 41β — meaning CVRX is approximately 128% more volatile than UHS relative to the S&P 500. On balance sheet safety, LifeStance Health Group, Inc. (LFST) carries a lower debt/equity ratio of 13% versus 129% for CVRx, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), LifeStance Health Group, Inc.

(LFST) is pulling ahead at 13. 9% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: LifeStance Health Group, Inc. grew EPS 113. 3% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, CVRX leads at 36. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Universal Health Services, Inc.

(UHS) is the more profitable company, earning 8. 6% net margin versus -94. 1% for CVRx, Inc. — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIVN leads at 14. 4% versus -90. 5% for CVRX. At the gross margin level — before operating expenses — UHS leads at 90. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Universal Health Services, Inc.

(UHS) trades at 7. 3x forward P/E versus 102. 7x for LifeStance Health Group, Inc. — 95. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVRX: 36. 6% to $10. 00.

In this comparison, UHS (0.

5% yield) pays a dividend. CVRX, LFST, LIVN, ACHC do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Universal Health Services, Inc.

(UHS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 62)). Both have compounded well over 10 years (UHS: +30. 3%, CVRX: -75. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CVRX is a small-cap quality compounder stock; LFST is a small-cap quality compounder stock; LIVN is a small-cap quality compounder stock; ACHC is a small-cap quality compounder stock; UHS is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.